Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Brian R. Martinotti U.S. District Judge Brian Martinotti. Courtesy photo

A federal judicial panel has transferred nearly 130 lawsuits to New Jersey brought over Janssen Pharmaceuticals’ pharmaceutical drug Elmiron.

The U.S. Judicial Panel on Multidistrict Litigation appointed U.S. District Judge Brian Martinotti to oversee the lawsuits, which allege that Elmiron, used to treat chronic bladder infection called interstitial cystitis, causes eye problems. Plaintiffs lawyers initially had split over whether the cases should go to New Jersey or Pennsylvania.

Want to continue reading?
Become a Free ALM Digital Reader.

Benefits of a Digital Membership:

  • Free access to 1 article* every 30 days
  • Access to the entire ALM network of websites
  • Unlimited access to the ALM suite of newsletters
  • Build custom alerts on any search topic of your choosing
  • Search by a wide range of topics

*May exclude premium content
Already have an account?

Amanda Bronstad

Amanda Bronstad is the ALM staff reporter covering class actions and mass torts nationwide. She writes the email dispatch Critical Mass. She is based in Los Angeles.

More from this author

Law Firms Mentioned

Reprints & Licensing
Mentioned in a Law.com story?

License our industry-leading legal content to extend your thought leadership and build your brand.


ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.